NPNittaya PhanuphakMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Innovative Clinical Models | Nittaya Phanuphak, MD, PhDView Slideset
MMMartin MarkowitzMDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Long Acting Antivirals for Treatment and Prevention | Martin Markowitz, MDView Slideset
JRJürgen RockstrohMDSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Hepatitis - HIV Co-infection | Jürgen Rockstroh, MDView Slideset
CLChing-Lung LaiMD, FRCP, FRACPSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Hepatitis C | Ching-lung Lai, MD, FRCP, FRACPView Slideset
DCDonn ColbyMD, MPHSlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Safety and efficacy of tenofovir disoproxil fumarate plus emtricitabine for HIV pre-exposure prophylaxis in Thailand | Donn Colby, MD, MPHView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Using the HVTN model to conduct HIV vaccine clinical trials | Xia Jin, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Tenofovir-induced kidney tubular dysfunction in HIV-infected patients in Hong Kong | Denise ChanView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2016Sensitive Detection of Tenofovir-induced Tubular Injury with Urinary ß-2 Microglobuline in Vietnam | Daisuke MizushimaView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016O_03 - A non-invasive lipidomic test accurately discriminates NASH from steatosis: a blind validation study | Dr. T. MontgomeryView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Microbiome: diagnostic considerations | Patrick GillevetView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Dynamic measurement of physiologic functions: any role in NASH diagnostics | Stephen Previs, MDView Slideset
SlidesetViral Hepatitis and Liver DiseaseInternational Workshop on NASH Biomarkers 2016Biomarker development in pediatric NAFLD: special challenges in a special population | Saul Karpen, MD, PhDView Slideset
